Neuroform EZ支架在颅内动脉狭窄治疗中的应用

Application of Neuroform EZ Stent in the Treatment of Intracranial Artery Stenosis

目的 探讨在颅内动脉狭窄疾病中采用Neuroform EZ支架的应用效果。方法 选取2021年1月—2023年1月北京京煤集团总医院接收的60例颅内动脉狭窄患者为研究对象,按照随机数表法分为对照组与研究组,每组30例。对照组采用传统支架治疗,研究组采取Neuroform EZ支架治疗。对比两组美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)评分、改良Rankin量表(Modified Rankin Scale,MRS)评分、脑血流灌注、并发症发生情况以及治疗效果。结果 治疗后3个月,研究组的NIHSS评分、MRS评分较治疗前降低且低于对照组,差异有统计学意义(P均<0.05)。对照组并发症发生率高于研究组,但差异无统计学意义(P>0.05)。研究组治疗总有效率为90.00%,高于对照组的73.33%,差异有统计学意义(χ^(2)=6.405,P=0.011)。结论 Neuroform EZ支架治疗颅内动脉狭窄属于有效方法,技术成功率高,可降低血管狭窄率,无病死情况,但存在一定并发症发生风险。

Objective To investigate the effect of Neuroform EZ stent in intracranial artery stenosis.Methods A total of 60 patients with intracranial artery stenosis admitted to Beijing Beijing Coal Group General Hospital from January 2021 to January 2023 were selected as the study objects and divided into control group and study group according to random number table method,with 30 patients in each group.The control group received traditional stent treatment,and the study group received Neuroform EZ stent treatment.The National Institutes of Health Stroke Scale(NIHSS) score,modified Rankin Scale(MRS) score,cerebral blood perfusion,complications and treatment effects were compared between the two groups.Results At 3 months after treatment,the scores of NIHSS and MRS in the study group were lower than those before treatment and the control group,and the differences were statistically significant(both P<0.05).The complication rate of control group was higher than that of study group,but the difference was not statistically significant(P>0.05).The total effective rate of the study group was 90.00%,which was higher than that of the control group(73.33%),the difference was statistically significant(χ^(2)=6.405,P=0.011).Conclusion Neuroform EZ stent is an effective method for the treatment of intracranial artery stenosis,with a high technical success rate,reducing the rate of vascular stenosis,and no death,but there is a certain risk of complications.